CYTO Stock Financials: Financial Performance and Reports

Period	FY-2023	FY-2022	FY-2021	FY-2020	FY-2019	FY-2018	FY-2017	FY-2016	FY-2015	FY-2014
Period Ended	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015	12/31/2014
Operating Revenue	$0.00	$305,616.00	$63,882.00	$174,475.00	-$56,000.00	$1.27 M	$322,000.00	-$414,000.00	-$67,000.00	$3.01 M
Cost of Revenue	$0.00	$1.44 M	$2.24 M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Gross Profit	$0.00	-$1.14 M	-$2.18 M	$174,475.00	-$56,000.00	$1.27 M	$322,000.00	-$414,000.00	-$67,000.00	$3.01 M
Gross Profit Ratio	0	-3.72	-34.07	1	1	1	1	1	1	1
Research and Development Expenses	$3.04 M	$19.68 M	$8.94 M	$2.86 M	$3.33 M	$6.69 M	$19.21 M	$24.78 M	$26.54 M	$17.70 M
General & Administrative Expenses	$3.09 M	$3.52 M	$4.90 M	$2.59 M	$3.93 M	$4.26 M	$5.15 M	$5.41 M	$4.34 M	$4.49 M
Selling & Marketing Expenses	$15,348.00	$2.38 M	$1.50 M	$95,663.00	$113,959.00	$43,816.00	$199,484.00	$45,649.00	$72,562.00	$237,720.00
Selling, General & Administrative Expenses	$3.12 M	$5.90 M	$6.39 M	$2.59 M	$3.93 M	$4.26 M	$5.15 M	$5.41 M	$4.34 M	$4.49 M
Other Expenses	$0.00	-$586,730.00	-$409,929.00	$0.00	$0.00	$215,720.00	$87,593.00	$34,055.00	$62,198.00	$73,434.00
Operating Expenses	$6.54 M	$24.99 M	$14.92 M	$5.46 M	$7.26 M	$10.95 M	$24.36 M	$30.22 M	$30.88 M	$22.19 M
Cost And Expenses	$6.54 M	$26.44 M	$17.16 M	$5.46 M	$7.26 M	$10.95 M	$24.36 M	$30.22 M	$30.88 M	$22.19 M
Interest Income	$730,195.00	$969.00	$3,219.00	$258.00	$17,882.00	$0.00	$53,570.00	$67,565.00	$37,000.00	$52,133.00
Interest Expense	$0.00	$911,869.00	$189,695.00	$135,151.00	$28,628.00	$1.07 M	$1.64 M	$828,547.00	$8,000.00	$49,635.00
Depreciation & Amortization	$5.92 M	$119,856.00	$79,576.00	$258.00	$17,882.00	$72,713.00	$122,784.00	$97,600.00	$92,777.00	$73,984.00
EBITDA	-$1.35 M	-$26.01 M	-$17.02 M	-$5.28 M	-$7.24 M	-$10.95 M	-$24.31 M	-$30.06 M	-$30.84 M	-$22.19 M
EBITDA Ratio	0	-85.12	-266.43	-30.28	129.31	-8.65	-75.49	72.6	460.31	-7.38
Operating Income	-$5.92 M	-$26.13 M	-$17.10 M	-$5.28 M	-$7.26 M	-$10.95 M	-$24.36 M	-$30.22 M	-$30.88 M	-$22.19 M
Operating Income Ratio	0	-85.51	-267.68	-30.28	129.63	-8.65	-75.66	73	460.87	-7.38
Total Other Income/Expenses Net	-$1.35 M	-$406,261.00	-$268,753.00	-$2.94 M	$433,406.00	$690,076.00	$1.52 M	$190,951.00	$1.14 M	$3.19 M
Income Before Tax	-$7.27 M	-$26.54 M	-$17.37 M	-$8.22 M	-$6.83 M	-$11.33 M	-$24.43 M	-$30.79 M	-$29.71 M	-$18.19 M
Income Before Tax Ratio	0	-86.84	-271.88	-47.12	121.89	-8.95	-75.86	74.38	443.36	-6.04
Income Tax Expense	-$1.35 M	-$10,329.00	$21,620.00	-$21,284.00	-$193,837.00	$162,177.00	-$17,773.00	-$131,055.00	-$84,777.00	-$892,177.00
Net Income	-$7.27 M	-$26.53 M	-$17.39 M	-$8.20 M	-$6.63 M	-$11.50 M	-$24.41 M	-$30.66 M	-$29.71 M	-$18.19 M
Net Income Ratio	0	-86.8	-272.22	-47	118.43	-9.08	-75.81	74.06	443.36	-6.04
EPS	-14.8	-582.58	-525.13	-545.41	-455.96	-2892.03	-22322.34	-35728.56	-36790.93	-26267.51
EPS Diluted	-14.8	-582.58	-525.13	-545.41	-455.96	-2892.03	-22322.34	-35728.56	-36790.93	-26267.51
Weighted Average Shares Out	$491,258.00	$45,536.00	$33,116.00	$15,035.00	$14,545.00	$3,975.20	$1,093.50	$858.20	$807.40	$692.30
Weighted Average Shares Out Diluted	$491,258.00	$45,536.00	$33,116.00	$15,035.00	$14,545.00	$3,975.20	$1,093.50	$858.20	$807.40	$692.30
Link

Altamira Therapeutics Ltd. (CYTO) Financials

Select an alert type

Setup alert

Log In

Email Verification

Welcome to StockNews!

Create Your Account

Email Verification